The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gaston-dreyfus Remi since 2019.
This trader's CIK number is 1716639.
At the time of last reporting, Gaston-dreyfus Remi was the Officer of Bionik Laboratories Corp.. (stock ticker symbol BNKL).
Also see all insider trading activities at Bionik Laboratories Corp..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | BNKL | 180,555 | $108,333 | 0 | $0 | 0 | $0 |
| 2021 | BNKL | 135,560 | $0 | 0 | $0 | 120,759 | $0 |
| 2019 | BNKL | 106,358 | $399,906 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-09 | BNKL | Buy | 180,555 | .60 | 108,333 |
| 2021-07-15 | BNKL | Option Ex | 120,759 | .00 | 0 |
| 2021-03-26 | BNKL | Buy | 135,560 | .00 | 0 |
| 2019-08-26 | BNKL | Buy | 106,358 | 3.76 | 399,906 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gaston-dreyfus Remi (Officer of Bionik Laboratories Corp. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.